The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well‐defined cohort

L van Iersel, RWH Meijneke… - Pediatric blood & …, 2018 - Wiley Online Library
Background Hypothalamic obesity (HO) is a major concern in patients treated for
craniopharyngioma (CP). The influence of degree of resection on development of HO, event …

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort: A risk factor analysis in a well-defined cohort

L van Iersel, RWH Meijneke… - Pediatric …, 2018 - researchinformation.amsterdamumc …
Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma
(CP). The influence of degree of resection on development of HO, event-free survival (EFS) …

[引用][C] The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort

L Iersel, RWH Meijneke… - Pediatric …, 2018 - scholarlypublications …
The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis
in a well-defined cohort | Scholarly Publications Skip to main content Universiteit Leiden …

[PDF][PDF] The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort

L van Iersel, RWH Meijneke, AYN Schouten-van… - mortality - liesbethreneman.com
Background: Hypothalamic obesity (HO) is a major concern in patients treated for
craniopharyngioma (CP). The influence of degree of resection on development of HO, event …

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort.

L van Iersel, RWH Meijneke… - Pediatric Blood & …, 2018 - europepmc.org
The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis
in a well-defined cohort. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort

L van Iersel, RWH Meijneke… - Pediatric blood & …, 2018 - research.rug.nl
The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis
in a well-defined cohort — the University of Groningen research portal Skip to main navigation …

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort

L van Iersel, RWH Meijneke… - Pediatric blood & …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Hypothalamic obesity (HO) is a major concern in patients treated for
craniopharyngioma (CP). The influence of degree of resection on development of HO, event …

[PDF][PDF] The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort

L van Iersel, RWH Meijneke, AYN Schouten-van… - mortality - liesbethreneman.com
Background: Hypothalamic obesity (HO) is a major concern in patients treated for
craniopharyngioma (CP). The influence of degree of resection on development of HO, event …